Eagle Pharmaceuticals
EGRX
#9990
Rank
A$26.79 M
Marketcap
$2.07
Share price
-12.85%
Change (1 day)
-73.86%
Change (1 year)

Earnings for Eagle Pharmaceuticals (EGRX)

Earnings in 2023 (TTM): A$52.93 Million

According to Eagle Pharmaceuticals 's latest financial reports the company's current earnings are A$0.25 Billion. In 2022 the company made an earning of A$0.10 Billion, an increase over its 2021 earnings that were of -A$4.82 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eagle Pharmaceuticals from 2013 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) A$52.93 M-51.42%
2022 A$0.10 B-2361.45%
2021 -A$4.82 Million-111.53%
2020 A$41.77 M2.31%
2019 A$40.82 M-32.89%
2018 A$60.83 M-50.35%
2017 A$0.12 B38.63%
2016 A$88.38 M1966.43%
2015 A$4.27 M-111.46%
2014 -A$37.34 Million282.82%
2013 -A$9.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$28.84 B 48,813.32%๐Ÿ‡บ๐Ÿ‡ธ USA
A$7.26 B 12,223.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$22.56 B 38,151.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-A$0.47 Billion-890.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
A$7.62 B 12,825.21%๐Ÿ‡บ๐Ÿ‡ธ USA
A$20.97 B 35,460.17%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$13.86 Billion-23,597.57%๐Ÿ‡บ๐Ÿ‡ธ USA